Efficacy and Tolerability of Fesoterodine in Older People With Overactive Bladder: Results of the Open-Label Phase of the SOFIA Trial

Wagg A1, Khullar V2, Marschall-Kehrel D3, Michel M C4, Oelke M5, Darekar A6, Ebel Bitoun C7, Osterloh I8, Weinstein D7

Abstract Category

Detrusor Overactivity

Abstract 341
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1. University of Alberta, 2. St Mary's Hospital, 3. Urological Consultancy, 4. University of Amsterdam, 5. Hannover Medical School, 6. Pfizer Ltd, 7. Pfizer France, 8. OsterMed Ltd